The currently evolving novel therapies for the management of hemophilia has ushered in a new era characterized by improved prophylaxis targets and outcomes. In this session from the WFH 2020 Virtual Summit, Johnny Mahlangu, Victor Blanchette, Robert Klamroth and Emna Gouider redefine prophylaxis in the modern era by revisiting its definition, presenting data to support […]
The freely available special Haemophilia Journal supplement dedicated to the WFH 2018 World Congress Glasgow (Vol 24, Issue Supplement S6 Pages 1–94) features reviews of the state of the art of each of the topics of the medical plenaries and sessions at the Congress, written by featured speakers.
Adapted from: Global NMO Training 2016 plenary presentation by Glenn PierceReviewed by: Glenn PierceEdited by: Georghia Michael This first eLearning module of the Treatment Products program explains how blood clots, how clotting factors work together in the coagulation cascade, what goes wrong in the case of factor deficiency, and how factor replacement therapy works by […]
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Anne Goodeve explains the classification of genetic variants in haemostasis.